Johnson & Johnson JNJ announced that the FDA has issued a complete response letter (“CRL”) to its biologics license ...

Dizal announces positive pooled data of sunvozertinib in EGFR TKI-resistant NSCLC: Shanghai, China Friday, December 13, 2024, 18:00 Hrs [IST] Dizal, a biopharmaceutical company co ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...

Among Taiwan’s non-small cell lung cancer cases, approximately 55 percent involve an EGFR mutation, with deletion of exon 19 and exon 21 the most common mutations, treatable with first to ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.

In a new study published in Lupus Science & Medicine, researchers found a connection between renal (kidney) response and long ...

The key secondary outcome was to assess the association between mPERR at index and survival without risk of mild CKD or worse during the follow-up period, defined as a new occurrence of GFR <60 mL/min ...

a huge increase in referrals to specialty renal clinics of patients with eGFR values of less than 60 ml/min/1.73 m 2 was noted. Anecdotes abound of similar experiences in the US. Some of these ...

The mean baseline eGFR was 77.2 mL/min/1.73 m², with 22.7% of participants having eGFR values below 60 mL/min/1.73 m². Eight trials administered interventions weekly, whereas others used daily ...

My sister and I locked eyes. This wasn’t going to work, was it? Ahead of us stretched narrow cobbled pavements and swarms of tourists. Join ST's Telegram channel and get the latest breaking ...